RegASK at LONDON BIOTECHNOLOGY SHOW 2026
RegASK combines agentic AI with regulatory expertise to help biotech teams navigate complexity and accelerate decisions. Act on regulatory changes across 160+ markets.
Meet us in London to discover how AI-powered regulatory intelligence can support your next product launch, market expansion or compliance initiative.
November 18–19, 2026 • ExCeL London, London, United Kingdom
THE REGULATORY REALITY
01
Manual monitoring reaches its limit
Regulatory updates arrive across multiple authorities, markets, and sources. Tracking changes manually makes it increasingly difficult to identify what matters, assess potential impact, and respond in time.
02
Europe’s regulations keep evolving
MDR and IVDR implementation, the revision of EU pharmaceutical legislation, and the EU AI Act reshape requirements at the same time. Strategies built on last quarter’s view carry risk into every submission.
03
Insight stalls before it becomes action
Intelligence that sits in reports and inboxes slows decisions. Regulatory change has to reach assessed impact, owned tasks, and documented outcomes.
RegASK is the Agentic AI Regulatory Operating System for life sciences and consumer products companies. Built on vertical AI and backed by a global network of 1,800+ regulatory subject matter experts, the platform anticipates regulatory change, assesses impact, and coordinates compliance activities across 160+ markets.
Agentic AI, expert intelligence, and enterprise governance bring regulatory work together in one system. With RegASK, you can replace manual monitoring across thousands of regulatory sources with relevant updates, prioritized workflows, and clear next steps, giving your teams greater speed, control, consistency, and traceable execution.
160+
Markets covered
1,800+
Subject matter experts
Know what is changing
Near real-time horizon scanning across 160+ markets, with impact assessments and prioritized alerts. Teams see what is coming before it arrives.
Act on what matters to you, autonomously
Automated workflows reduce time to market and let your team focus on what matters: strategy.
Connect your ecosystem
Open API, MCP support, pre-built connectors, and enterprise SSO for Veeva Vault makes RegASK the regulatory intelligence layer across your entire ecosystem.
Trust your compliance posture
Move from intelligence to coordinated regulatory work with governed workflows, clear ownership, and traceable execution.
MEET US IN LONDON
Peter Reynolds will be in London on November 18–19. He will share how RegASK turns near real-time regulatory intelligence from 160+ markets into assessed impact and governed, audit-ready workflows.
Peter Reynolds 
Director, Client Engagement, RegASK
Peter Reynolds is a Director, Client Engagement at RegASK. He brings extensive international enterprise sales experience across regulatory, quality, and pharmacovigilance teams in European and US life sciences markets. At LONDON BIOTECHNOLOGY SHOW 2026, he is available to walk through how RegASK connects regulatory monitoring, impact assessment, and governed workflows for healthcare regulatory teams.
If the available time slots don’t work for you, feel free to reach out to Peter at peter.reynolds@regask.com to learn more about RegASK.
LONDON BIOTECHNOLOGY SHOW 2026
London Biotechnology Show 2026 takes place November 18–19 at ExCeL London, bringing together global leaders, innovators, and industry experts to explore the latest advancements in biotechnology, healthcare, and life sciences. The event focuses on accelerating innovation, fostering strategic partnerships, and advancing the future of healthcare.
Conference sessions cover biopharmaceuticals, gene and cell therapies, precision medicine, AI-driven drug discovery, medical devices, and clinical trials. Key discussions also explore biomanufacturing, regulatory compliance, and emerging technologies shaping the industry. Through expert-led sessions, exhibitions, and networking opportunities, the event aims to foster collaboration, accelerate scientific breakthroughs, and support the commercialization of innovative healthcare solutions.
Professionals across the biotechnology, pharmaceutical, and healthcare sectors, including regulatory affairs leaders, researchers, clinical research organizations, biotech innovators, healthcare providers, policymakers, investors, and technology specialists involved in drug development, regulatory compliance, and commercialization.
Biotechnology and pharmaceutical companies are accelerating innovation across biologics, gene and cell therapies, precision medicine, and AI-driven drug discovery. As these technologies advance, regulatory compliance, clinical development, and commercialization become increasingly complex. Teams that anticipate regulatory requirements, streamline workflows, and turn regulatory intelligence into actionable insights can reduce risks, accelerate development, and bring innovative therapies to market with greater confidence.
AI-driven regulatory intelligence for biotechnology and life sciences, timely regulatory monitoring, automated impact assessments, and streamlined workflows to navigate complex requirements, reduce compliance risks, and accelerate market access. Bring your own use cases.
Use the scheduler on this page to book an in-person meeting with Peter Reynolds. If the available slots don’t suit you, email Peter at peter.reynolds@regask.com.
Meet Peter Reynolds to discuss your regulatory intelligence challenges and priorities. Share your products and target markets in advance so he can prepare relevant regulatory information and demonstrate how RegASK connects regulatory changes with actionable workflows.
London Biotechnology Show 2026 takes place November 18–19, 2026, at ExCeL London, Royal Victoria Dock, 1 Western Gateway, London E16 1XL, United Kingdom. The event brings together biotechnology, pharmaceutical, and healthcare professionals to explore advancements in life sciences, emerging technologies, and innovations shaping the future of healthcare.
Yes. RegASK is attending LONDON BIOTECHNOLOGY SHOW 2026. Our team will share how agentic AI turns regulatory change into assessed impact and governed action for healthcare regulatory teams worldwide.
Peter Reynolds, Director, Client Engagement will represent RegASK in London. He is available on both show days.
RegASK is the Agentic AI Regulatory Operating System for life sciences and consumer products companies. It monitors regulatory change across 160+ markets, assesses impact, and orchestrates the resulting workflows, backed by 1,800+ subject matter experts. RegASK operates upstream of submission and does not file applications with health authorities.
Meet our team to see how RegASK connects regulatory intelligence, Decision Intelligence, and agentic AI in one governed system.
Book a Meeting